Suppr超能文献

羧酸酯酶同工酶的底物特异性及其对人肝脏和小肠水解酶活性的贡献。

Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine.

作者信息

Imai Teruko, Taketani Megumi, Shii Mayumi, Hosokawa Masakiyo, Chiba Kan

机构信息

Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-Honmachi, Kumamoto 862-0973, Japan.

出版信息

Drug Metab Dispos. 2006 Oct;34(10):1734-41. doi: 10.1124/dmd.106.009381. Epub 2006 Jul 12.

Abstract

Hydrolase activity from human liver and small intestine microsomes was compared with that of recombinant human carboxylesterases, hCE-1 and hCE-2. Although both hCE-1 and hCE-2 are present in human liver, the dominant component was found to be hCE-1, whereas the hydrolase activity of the human small intestine was found to be predominantly hCE-2. hCE-2 has a limited ability to hydrolyze large acyl compound substrates. Interestingly, propranolol derivatives, good substrates for hCE-2, were easily hydrolyzed by substitution of the methyl group on the 2-position of the acyl moiety, but were barely hydrolyzed when the methyl group was substituted on the 3-position. These findings suggest that hCE-2 does not easily form acylated intermediates because of conformational interference in its active site. In contrast, hCE-1 could hydrolyze a variety of substrates. The hydrolytic activity of hCE-2 increased with increasing alcohol chain length in benzoic acid derivative substrates, whereas hCE-1 preferentially catalyzed the hydrolysis of substrates with short alcohol chains. Kinetic data showed that the determining factor for the rate of hydrolysis of p-aminobenzoic acid esters was V(max) for hCE-1 and K(m) for hCE-2. Furthermore, the addition of hydrophobic alcohols to the reaction mixture with p-aminobenzoic acid propyl ester induced high and low levels of transesterification by hCE-1 and hCE-2, respectively. When considering the substrate specificities of hCE-1, it is necessary to consider the transesterification ability of hCE-1, in addition to the binding structure of the substrate in the active site of the enzyme.

摘要

将人肝脏和小肠微粒体的水解酶活性与重组人羧酸酯酶hCE - 1和hCE - 2的水解酶活性进行了比较。虽然hCE - 1和hCE - 2都存在于人肝脏中,但发现主要成分是hCE - 1,而人小肠的水解酶活性主要是hCE - 2。hCE - 2水解大的酰基化合物底物的能力有限。有趣的是,hCE - 2的良好底物普萘洛尔衍生物,通过酰基部分2位甲基的取代很容易被水解,但当甲基取代在3位时几乎不被水解。这些发现表明,由于hCE - 2活性位点的构象干扰,它不容易形成酰化中间体。相比之下,hCE - 1可以水解多种底物。在苯甲酸衍生物底物中,hCE - 2的水解活性随着醇链长度的增加而增加,而hCE - 1优先催化短醇链底物的水解。动力学数据表明,对氨基苯甲酸酯水解速率的决定因素对于hCE - 1是V(max),对于hCE - 2是K(m)。此外,在含有对氨基苯甲酸丙酯的反应混合物中加入疏水醇,分别诱导hCE - 1和hCE - 2发生高水平和低水平的酯交换反应。在考虑hCE - 1的底物特异性时,除了底物在酶活性位点的结合结构外,还必须考虑hCE - 1的酯交换能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验